Literature DB >> 8261563

The costs of HIV prevention strategies in developing countries.

N Söderlund1, J Lavis, J Broomberg, A Mills.   

Abstract

Since many evaluations of HIV (human immunodeficiency virus) prevention programmes do not include data on costs, a preliminary analysis of the costs and outputs of a sample of HIV prevention projects was attempted. Case studies, representing six broad HIV prevention strategies in developing countries with differing levels of per capita gross domestic product, were sought on the basis of availability of data and potential generalizability. The six prevention strategies studied were mass media campaigns, peer education programmes, sexually transmitted disease treatment, condom social marketing, safe blood provision, and needle exchange/bleach provision programmes. Financial cost data were abstracted from published studies or were obtained directly from project coordinators. Although estimates of cost-effectiveness were not made, calculations of the relative cost per common process measure of output were compared. Condom distribution costs ranged from US$ 0.02 to 0.70 per condom distributed, and costs of strategies involving personal educational input ranged from US$ 0.15 to 12.59 per contact.

Entities:  

Mesh:

Year:  1993        PMID: 8261563      PMCID: PMC2393468     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  First principles of cost-effectiveness analysis in health.

Authors:  D S Shepard; M S Thompson
Journal:  Public Health Rep       Date:  1979 Nov-Dec       Impact factor: 2.792

2.  Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group.

Authors:  S Moses; F A Plummer; E N Ngugi; N J Nagelkerke; A O Anzala; J O Ndinya-Achola
Journal:  AIDS       Date:  1991-04       Impact factor: 4.177

Review 3.  Research on AIDS interventions in developing countries: state of the art.

Authors:  D Schopper
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

  3 in total
  6 in total

Review 1.  The impact of HIV and AIDS on Africa's economic development.

Authors:  Simon Dixon; Scott McDonald; Jennifer Roberts
Journal:  BMJ       Date:  2002-01-26

Review 2.  Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.

Authors:  Mariana Siapka; Michelle Remme; Carol Dayo Obure; Claudia B Maier; Karl L Dehne; Anna Vassall
Journal:  Bull World Health Organ       Date:  2014-04-01       Impact factor: 9.408

3.  Implementing HIV Prevention in Sub-Saharan Africa: A Systematic Review of Interventions Targeting Systems, Communities, and Individuals.

Authors:  Sarah F Rapaport; Austin D Peer; Nikita Viswasam; Elizabeth Hahn; Sofia Ryan; Gnilane Turpin; Carrie E Lyons; Stefan Baral; Bhakti Hansoti
Journal:  AIDS Behav       Date:  2022-08-01

4.  Spatial distribution and cluster analysis of sexual risk behaviors reported by young men in Kisumu, Kenya.

Authors:  Nelli Westercamp; Stephen Moses; Kawango Agot; Jeckoniah O Ndinya-Achola; Corette Parker; Kevine O Amolloh; Robert C Bailey
Journal:  Int J Health Geogr       Date:  2010-05-22       Impact factor: 3.918

5.  Cost-Effectiveness Analysis of Hospitalization and Home-Based Care Strategies for People Living with HIV/AIDS: The Case of Zimbabwe.

Authors:  Senelani D Hove-Musekwa; Farai Nyabadza; Hermane Mambili-Mamboundou; Christinah Chiyaka; Zindoga Mukandavire
Journal:  Int Sch Res Notices       Date:  2014-09-28

6.  HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.

Authors:  Elliot Marseille; Lalit Dandona; Nell Marshall; Paul Gaist; Sergio Bautista-Arredondo; Brandi Rollins; Stefano M Bertozzi; Jerry Coovadia; Joseph Saba; Dmitry Lioznov; Jo-Ann Du Plessis; Evgeny Krupitsky; Nicci Stanley; Mead Over; Alena Peryshkina; S G Prem Kumar; Sowedi Muyingo; Christian Pitter; Mattias Lundberg; James G Kahn
Journal:  BMC Health Serv Res       Date:  2007-07-12       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.